Klaria announces positive pre-clinical proof-of-concept study results with the Cannabinoid CBD, superior data on both tested outcome measures demonstrated
(WorldNews Sweden)

The PoC study was positive on both key measures, which were 1) time to clinically/medically relevant blood concentration of CBD with the film formulation vs an oral formulation and 2) bioavailability of CBD with the film formulation vs an oral formulation. Specifically, the time to medically relevant concentration was reduced by more than 50% to less than 20 minutes for the film vs...